Riskpilot← Back to searchSign inGet full accessBYBV AB
ABActiveOrg 5593219552Pumpgatan 1Medical specialists activities · NACE 8622Est. 20210 employees
Revenue 2025
SEK 508K
-19% vs 2024
EBITDA margin
-11.2%
-38260% vs 2024
Equity ratio
74.5%
Financial strength
Net profit 2025
SEK -57K
-31902% vs 2024
| Revenue | SEK 508K | -19% |
| EBITDA | SEK -57K | -38260% |
| Net profit | SEK -57K | -31902% |
| Total assets | SEK 52K | -52% |
| Equity | SEK 39K | -59% |
| Employees | 0 | — |
Legal name
BYBV AB
Org number
5593219552
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
10 juni 2021
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är utbildning och forskning inom medicin, medicinsk konsultation, uthyrning och rekrytering av personal inom vården, rådgivning och coaching, utbildning inom organisationsutveckling och ledarskap samt management konsult.
Address
Pumpgatan 1
Email
florin@becomeyourbestversion.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 462 | 165 | 543 | 624 | 508 |
| Staff expenses | — | −0 | −30 | −0 | −0 |
| EBITDA | 12 | 38 | 38 | −0 | −57 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 12 | 38 | 38 | −0 | −57 |
| Net financials | — | 0 | 0 | 1 | 0 |
| Profit before tax | 13 | 38 | 38 | 0 | −57 |
| Tax | −3 | −8 | −8 | −0 | — |
| Net profit | 10 | 30 | 30 | 0 | −57 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 123 | 104 | 212 | 108 | 52 |
| Equity | 35 | 65 | 96 | 96 | 39 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 88 | 39 | 116 | 12 | 13 |
| Total debt | 88 | 39 | 116 | 12 | 13 |
EBITDA margin
-11.2%
This company
15.8%
Market median
-171% vs market
20212025
Equity ratio
74.5%
This company
38.2%
Market median
+95% vs market
20212025
Return on equity
-146.4%
This company
18.4%
Market median
-896% vs market
20212025
Net profit margin
-11.2%
This company
8.1%
Market median
-238% vs market
20212025
Asset turnover
9.74×
This company
1.12×
Market median
+770% vs market
20212025
Debt / equity
0.34×
This company
0.62×
Market median
+45% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-06-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BYBV AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Florin Gabriel Lungu | Board of Directors | 0 companies |
| Florina Loredana Lungu | Deputy Board Member | 0 companies |